insights_auto
Why is GH down 2,04%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
151,70 $
arrow_downward
-2,04%(-3,16) 1D
151,70 $
0,00% (0,00)
bedtimeAfter hours
Closed: 13 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
156,02 $
High
156,02 $
Low
148,01 $
Mkt. cap
20,52 մլրդ
Avg. vol.
2,13 մլն
Volume
1,29 մլն
52-wk high
191,05 $
52-wk low
74,55 $
EPS
-3,68 $
Beta
1,67
Shares outstanding
135,29 մլն
No. of employees
2 հզր
Open
156,02 $
High
156,02 $
Low
148,01 $
Mkt. cap
20,52 մլրդ
Avg. vol.
2,13 մլն
Volume
1,29 մլն
52-wk high
191,05 $
52-wk low
74,55 $
EPS
-3,68 $
Beta
1,67
Shares outstanding
135,29 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Investing.com
·
2 օր առաջ
Guardant Health plans $500 million convertible notes offering
Trefis
·
2 օր առաջ
Could You Have Seen The Run In Guardant Health Stock Coming?
Seeking Alpha
·
3 օր առաջ
Guardant Health, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:GH) 2026-11-10
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com